Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Saptak Chem & Business Ltd

SCBL
BSE
45.22
1.70%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Saptak Chem & Business Ltd

SCBL
BSE
45.22
1.70%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
14Cr
Close
Close Price
45.22
Industry
Industry
Trading
PE
Price To Earnings
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
800.00%
Peer Comparison
How does SCBL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SCBL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
-100.0-100.0-100.0-100.0
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-100.0-100.0-200.0100.0-166.7
NPM
NPM%
EPS
EPS
0.00.00.00.00.00.00.00.0-0.1-0.1-0.2-1.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
000100000000
Growth
Revenue Growth%
1,608.1-79.2-100.0-50.1128.0-100.0
Expenses
ExpensesCr
000100000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
2.08.44.7-14.15.47.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
100000000000
Tax
TaxCr
000000000000
PAT
PATCr
100000000000
Growth
PAT Growth%
-109.0102.15,400.1-87.9-162.9-141.0109.8190.0-698.3-148.4-213.2
NPM
NPM%
2.68.44.9-27.75.46.9
EPS
EPS
1.0-0.10.00.10.00.00.00.00.00.0-0.1-1.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
11111111111111111111111
Reserves
ReservesCr
-13-13-13-13-13-13-13-13-13-13-13-3
Current Liabilities
Current LiabilitiesCr
022444444223
Non Current Liabilities
Non Current LiabilitiesCr
200000000000
Total Liabilities
Total LiabilitiesCr
000222222000
Current Assets
Current AssetsCr
000211111000
Non Current Assets
Non Current AssetsCr
000011111000
Total Assets
Total AssetsCr
000222222000

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
100000000-10
Investing Cash Flow
Investing Cash FlowCr
00000000000
Financing Cash Flow
Financing Cash FlowCr
-10000000010
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
100000000-10
CFO To PAT
CFO To PAT%
100.0100.0-4,138.76.5-476.5100.0-39.6-5,940.02,203.41,884.464.5
CFO To EBITDA
CFO To EBITDA%
-912.399.1-5,501.06.4-495.0100.0-78.0-5,940.02,166.11,884.464.1

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00007300343
Price To Earnings
Price To Earnings
0.00.00.00.0612.00.00.00.0282.00.00.0
Price To Sales
Price To Sales
0.00.023.50.00.037.9
Price To Book
Price To Book
0.00.00.00.0-3.1-1.50.00.0-1.4-1.9-1.5
EV To EBITDA
EV To EBITDA
-17.2-22.91,557.124.2718.9-699.3-265.21,438.8979.6-182.3-66.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.016.028.5100.062.893.2
OPM
OPM%
2.08.44.7-14.15.47.0
NPM
NPM%
2.68.44.9-27.75.46.9
ROCE
ROCE%
-951.8-4,939.91.618.02.1-1.3-3.20.30.8-21.8-77.1
ROE
ROE%
-50.14.3-0.1-5.2-0.60.40.9-0.1-0.31.63.8
ROA
ROA%
8,789.5-272.71.16.00.8-0.5-1.40.10.4-21.5-63.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Saptak Chem and Business Limited (formerly **Munak Chemicals Limited**) is an Indian listed entity currently undergoing a fundamental strategic pivot. After decades of volatility in the fertilizer and chemical manufacturing sectors, the company has transitioned into a lean, **trading-centric business model** focused on **agricultural produce and chemicals**. To facilitate this recovery, the company has executed a drastic **90% capital reduction** to eliminate legacy losses and is actively raising fresh capital to fund its entry into the high-volume agri-retail market. --- ### **Strategic Pivot: From Legacy Chemicals to Agri-Trading** The company has historically struggled with the **Single Super Phosphate (SSP)** fertilizer segment due to high raw material volatility and the withdrawal of government subsidies. Consequently, management has shifted focus toward the **retail trading of agricultural produce** and **perishable goods**. * **High-Value Order Win:** In **September 2025**, the company secured a significant contract valued at **₹5.50 Crores** from **Shree Nakoda Agro Trading**. This contract involves the supply of **Banana, Tomato, Onion, and Sapota**, providing clear revenue visibility through **FY 2025-26** and **FY 2026-27**. * **Diversified Trading Mandate:** While currently focused on domestic agri-trade, the company’s Memorandum of Association (MoA) permits extensive operations across organic/inorganic chemicals, industrial salt, and construction initiatives. * **Geographical Focus:** Operations are currently concentrated exclusively within **India**, managed as a single reporting segment. --- ### **Capital Restructuring & Financial Engineering** To address a legacy of accumulated losses—which reached **₹12.87 Crore** by March 2023—the company implemented a court-approved **Scheme of Capital Reduction** in **June 2025**. | Restructuring Event | Date | Impact/Details | | :--- | :--- | :--- | | **90% Capital Reduction** | **June 2025** | Reduced paid-up capital from **₹10.73 Crore** to **₹1.07 Crore** to write off **₹9.66 Crore** in losses. | | **Share Consolidation** | **July 2025** | Shareholders received **10 equity shares** for every **100 shares** held. | | **Preferential Warrant Issue** | **Jan 2026** | Allotment of **40,00,000 warrants** at **₹10.50** each (Total: **₹4.20 Crore**). | | **Warrant Conversion** | **Apr 2026** | **20,00,000 warrants** converted to equity; raised **₹1.575 Crore** in fresh capital. | | **Borrowing Authorization** | **May 2023** | Board approval to borrow up to **₹500 Crores** for future scaling. | As of **April 2026**, the post-restructuring paid-up equity capital stands at **₹3,07,32,270** (comprising **30,73,227** shares), with **20,00,000** warrants still outstanding. --- ### **Operational Infrastructure & Governance** The company has overhauled its administrative structure to support its new trading operations and reduce overhead costs. * **Headquarters Relocation:** In **January 2026**, the company approved shifting its registered office to **Ahmedabad (Naranpura)**. This follows a series of moves since 2023 aimed at centralizing Sales, IT, and Finance teams to improve coordination and reduce administrative leakage. * **Leadership Transition:** * **Mr. Ayush Vinod Kumar Tated** was appointed **Managing Director** for a 5-year term starting **January 9, 2026**. * The MD acts as the **Chief Operating Decision Maker (CODM)**, overseeing a lean organizational structure. * **Internal Controls:** The company utilizes **external audit firms** for system reviews and has implemented a **self-certification** process for process owners. **M/s. P H SHAH & CO** was appointed as the Statutory Auditor in **October 2025**. --- ### **Financial Performance & Liquidity Profile** The company is in a "recovery phase," characterized by low operational activity in recent years and a focus on cleaning the balance sheet. | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :---: | :---: | :---: | | **Net Profit/Loss** | **(₹8.62 Lacs)** | -- | -- | | **Current Ratio** | **0.07** | **0.07** | **0.28** | | **Debt Equity Ratio** | **0.00** | **0.00** | **-1.35** | | **Operating Profit Margin** | **--** | **--** | **7.03%** | * **Liquidity Constraints:** The company faces a persistent **liquidity crunch**, making it difficult to secure traditional bank financing. Current operations are supported by fresh equity infusions and **Unsecured Loans** from the holding company totaling **₹2.33 Crore** (non-interest bearing and repayable on demand). * **Asset Valuation:** Management maintains that current assets and loans are stated at realizable values, and no provision for **Expected Credit Loss (ECL)** is currently deemed necessary. --- ### **Risk Matrix & Regulatory Outlook** Investors should note several critical risk factors associated with the company’s transition and historical compliance record. #### **1. Regulatory & Legal Risks** * **Tax Litigation:** A disputed **GST demand of ₹1.19 Crore** for FY 2018-19 is currently pending before the Assistant Commissioner of Central Tax. * **Compliance Lapses:** The company has faced challenges with **SEBI Regulation 47**, specifically failing to publish certain board meeting notices and financial results in newspapers. There have also been "slight delays" in depositing **Income Tax** and **Provident Fund** dues. #### **2. Market & Operational Risks** * **Sector Sensitivity:** The agri-trading business is highly dependent on monsoon patterns and Government of India policies. The previous failure of the SSP fertilizer business serves as a precedent for how policy shifts (subsidy withdrawals) can impact the bottom line. * **Commodity Volatility:** Exposure to price fluctuations in perishables is managed through **forward booking** and inventory management, though margins remain thin. * **Reconciliation:** Certain balances for **sundry creditors, debtors, and loans** are still subject to ongoing confirmation and reconciliation, which may lead to future adjustments. #### **3. Human Capital Risk** * As a lean organization, the ability to attract and retain specialized trading talent is a primary risk. The company is attempting to mitigate this through a new **strategic talent management system** and integrated learning activities.